Microarchitecture, Bone Strength and Fracture Risk in Type 2 Diabetes (DiabOS)
Microarchitecture, Bone Strength and Fracture Risk in Type 2 Diabetes: the DiabOS Study
Sponsor: University Hospital Schleswig-Holstein
A observational or N/A phase clinical study on Bone Fractures and Type 2 Diabetes Mellitus, this trial is completed. The trial is conducted by University Hospital Schleswig-Holstein and has accumulated 15 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Mar 2022 — Jan 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 10 earlier versions
-
Dec 2021 — Mar 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jan 2020 — Nov 2020 [monthly]
Recruiting
-
Feb 2019 — Jan 2020 [monthly]
Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital Schleswig-Holstein
- University Hospital, Basel, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .